Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-05-13T01:10:07.261Z Has data issue: false hasContentIssue false
  • English
  • Français

Anaesthesia for a life-limited child with adrenoleucodystrophy

Published online by Cambridge University Press:  23 December 2004

G. Dobson  and
J. Lyons
G. Dobson
Affiliation:
Department of Anaesthesia, The Royal Belfast Hospital for Sick Children, Belfast, N. Ireland
J. Lyons
Affiliation:
Department of Anaesthesia, The Royal Belfast Hospital for Sick Children, Belfast, N. Ireland
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
European Journal of Anaesthesiology , Volume 21 , Issue 1 , January 2004 , pp. 78 - 79
Copyright
2004 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Stephenson DJ, Bezman L, Raymond GV. Acute presentation of childhood adrenoleukodystrophy. Neuropediatrics 2000; 31: 293–297.Google Scholar
Kindopp AS, Ashbury T. Anaesthetic management of an adult patient with X-linked adrenoleukodystrophy. Can J Anaesth 1998; 45: 990–992.Google Scholar
Schwartz RE, Stayer SA, Pasquariello CA, Lowe DA, Foster CJ. Anaesthesia for the patient with neonatal adrenoleukodystrophy. Can J Anaesth 1994; 41: 56–58.Google Scholar
Tobias JD. Anaesthetic considerations for the child with leukodystrophy. Can J Anaesth 1992; 39: 394–397.Google Scholar
Cooperman LH. Succinylcholine-induced hyperkalemia in neuromuscular disease. JAMA 1970; 213: 1867–1871.Google Scholar
Driessen JJ, Wuis EW, Gielen MJ. Prolonged vecuronium neuromuscular blockade in a patient receiving orally administered dantrolene. Anesthesiology 1985; 62: 523–524.Google Scholar
Watson CB, Reierson N, Norfleet EA. Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia. Anesthesiology 1986; 65: 312–314.Google Scholar